What is the phone number of Xiayi County Medical Insurance Bureau?

For employee medical insurance, please contact 0370-3033601; for residents’ medical insurance, please contact 0370-6113196. At the same time, you can also call the national unified social security consultation hotline: 12333; consultation and appointment hotline: 0370-3031167, medical assistance consultation hotline: 15137018999; serious illness second reimbursement consultation hotline: 17337023979 serious illness; fourth reimbursement consultation hotline for people in need: 0370-6666158 .

: About the Medical Security Bureau

After the establishment of the Medical Security Bureau, it will become the government department that pharmaceutical companies and medical equipment companies care most about. There are three reasons:

1. Market access

For the domestic pharmaceutical industry, what is market access? We can understand it in a narrow sense as: bidding and medical insurance.

If the drugs cannot pass the bidding, they will lose the entire hospital market. In addition, if a drug cannot be included in the medical insurance catalog, even through bidding, it will have a great impact on its market.

Tendering and the medical insurance catalog are both market access. Now these two rights have fallen into the hands of the Medical Insurance Bureau, and their importance is self-evident.

2. Strictly control drug use

Controlling medical insurance costs is obviously still a key word in 2018. With the big move to control medical insurance costs, for pharmaceutical companies, entering the catalog is just a threshold, and hospital access and medical insurance payment standards are top priorities.

The Medical Security Bureau has the power to control costs from the source and directly control previously high-dose drugs and auxiliary drugs. In addition, according to the medical insurance payment standards, the hospital will prompt the patient to use the lowest-cost drug on the basis of rational drug use. In the future, in the medical insurance environment, the game of interests of all parties will become more obvious.

3. Directly determine drug prices

Previously, the National Development and Reform Commission was responsible for setting drug prices, the Ministry of Human Resources and Social Security was responsible for the medical insurance catalog, and the Health and Family Planning Commission was responsible Procured through bidding, ultimately paid for by medical insurance. Those who spend money can't talk about prices and standardize usage, leading to increasing pressure on Medicare.

Nowadays, the Medical Security Bureau takes over the bidding and procurement of drugs, which on the one hand embodies "who pays, who makes the market." On the other hand, in the case of actual medical insurance funds, the winning bid price of drugs will be closely integrated with the medical insurance payment standards, thereby maximizing the interests of all parties.

In this case, the hospital or medical alliance can negotiate the price of the drug based on Medicare payment standards. They can even entrust third-party platforms to negotiate drugs with the local medical insurance bureau. There is only one end goal. On the basis of medical insurance payment standards, drug prices will be reduced to maximize benefits.

It can be said that medical insurance will directly affect the fate of pharmaceutical companies and even enterprises from multiple angles. With the Healthcare Safety Authority at the helm.